Immunogenicity and safety of the non-typable Haemophilus influenzae–Moraxella catarrhalis (NTHi-Mcat) vaccine administered following the recombinant zoster vaccine versus administration alone: Results from a randomized, phase 2a, non-inferiority trial
暂无分享,去创建一个
V. Anttila | A. Borobia | O. Launay | D. Casula | A. Arora | S. Milleri | Luca Grassano | A. Tasciotti | Marie Dozot | M. Testa | I. Galgani | A. Põder | R. Jõgi